Search

everythinglearnresearchcommunity

for

Search:↓

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Treatment with vitamin A did not improve the child's skin condition.

The patient was diagnosed with hypothyroidism and treated with medication and supplements.

Chemotherapy and radiotherapy do not significantly affect obstructive sleep apnea development.

Low dose oral minoxidil is safe for treating hair loss in men.

Adverse reactions to isotretinoin in acne treatment are common and mainly linked to treatment duration.

CHOP chemotherapy for non-Hodgkin's lymphoma commonly causes hair loss, fatigue, taste changes, and nausea.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Patients on hemodialysis commonly have skin color changes, nail problems, dry skin, and itching.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

Cetuximab can cause eyelash growth, which is rare but manageable.

Oral minoxidil may effectively treat hair loss from chemotherapy.

Tooth loss can cause premature gray hair due to less chewing.

Zinc deficiency in alcoholic cirrhosis patients causes skin issues and other symptoms, which improve with zinc treatment.

Topical glycopyrrolate lotion helped reduce excessive sweating from eating in a diabetic man.

The combined treatment effectively managed severe skin issues in Olmsted syndrome.

Most patients on isotretinoin for acne experience mild, dose-related side effects, but the connection to depression or bowel disease is uncertain.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

Smoking can cause yellowing of upper lip hair.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Oral dutasteride, minoxidil, and finasteride may help reduce hair loss in breast cancer survivors, but more research is needed.

A cancer drug caused unusual hair growth on a 100-year-old man's scalp and eyelashes.

Cronkhite-Canada syndrome is rare, has a poor prognosis, and requires early diagnosis and ongoing treatment.

A patient with Cronkhite-Canada syndrome improved with nutritional support and steroids, but early diagnosis is key due to high mortality.

Alpha-tocopherol does not prevent hair loss from doxorubicin.

A 46-year-old man showed symptoms of a rare condition usually seen in postmenopausal women, highlighting the need for dentist-dermatologist collaboration.